Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation.
Patel A, Wilkerson K, Chen H, Sharma D, Byrne M, Green J, Sengsayadeth S, Dholaria B, Savani B, Chinratanalab W, Jayani R, Gatwood K, Engelhardt BG, Kitko C, Connelly J, Kassim A.
Patel A, et al. Among authors: sharma d.
Transplant Cell Ther. 2022 May;28(5):277.e1-277.e6. doi: 10.1016/j.jtct.2022.02.010. Epub 2022 Feb 15.
Transplant Cell Ther. 2022.
PMID: 35181561
Free article.